Your session is about to expire
← Back to Search
iParent2Parent Support Program for Solid Organ Transplant Parents
N/A
Recruiting
Led By Samantha J. Anthony, PhD, MSW
Research Sponsored by The Hospital for Sick Children
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to program completion, an average of one year
Awards & highlights
Study Summary
This trial matches parents of pediatric SOT recipients with trained mentors to provide peer support and mentorship. It aims to reduce isolation, improve mental health, and have a long-term positive impact on patient health.
Who is the study for?
This trial is for parents of children under 18 who had a solid organ transplant at least two months ago, or under 21 if they're one year post-transplant. They need to speak English and have access to WhatsApp on a device. To be mentors, they must be recommended by their child's healthcare team.Check my eligibility
What is being tested?
The iParent2Parent Program connects parents of pediatric SOT recipients with trained parent mentors through virtual mentorship. The study will assess whether this program helps reduce isolation and improve mental health among these parents.See study design
What are the potential side effects?
Since the intervention involves peer support and not medical treatment, there are no direct physical side effects expected from participating in the iParent2Parent Program.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline to program completion, an average of one year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to program completion, an average of one year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acceptability (Mentees)
Acceptability (Mentors)
Adherence with the iParent2Parent program
+5 moreSecondary outcome measures
Coping (Mentees and Mentors)
Family Functioning (Mentees and Mentors)
Parenting stress (Mentees and Mentors)
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: iParent2Parent ProgramExperimental Treatment1 Intervention
Group II: Standard of Care Waitlist Control GroupActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
iParent2Parent Program
2019
N/A
~10
Find a Location
Who is running the clinical trial?
The Hospital for Sick ChildrenLead Sponsor
692 Previous Clinical Trials
6,946,545 Total Patients Enrolled
2 Trials studying Solid Organ Transplant
115 Patients Enrolled for Solid Organ Transplant
Samantha J. Anthony, PhD, MSWPrincipal InvestigatorThe Hospital for Sick Children
1 Previous Clinical Trials
55 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a parent of a child who had an organ transplant over 2 months ago, have WhatsApp, and speak English.I am a parent of a child who had an organ transplant over a year ago, nominated to be a mentor, and can use WhatsApp.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care Waitlist Control Group
- Group 2: iParent2Parent Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger